Stocktoria
Evolent Health, Inc. EVH
NYSE · XNYS · stock · Services-Management Services · website · IPO 2015-06-05
Chart by TradingView
4/9
Piotroski F — financial health
-3
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $1.9B | $2.6B | $2.0B | $1.4B | $908.0M |
| Operating income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$42.4M |
| Net income | -$534.5M | -$61.6M | -$113.0M | -$19.2M | -$37.6M |
| Operating cash flow | $38.8M | $18.8M | $142.6M | -$11.6M | $38.7M |
| Total assets | $1.9B | $2.5B | $2.7B | $1.8B | $1.4B |
| Total liabilities | $1.5B | $1.4B | $1.4B | $957.9M | $725.8M |
| Shareholders' equity | $415.2M | $1.0B | $1.1B | $859.4M | $693.6M |
| Ratios | |||||
| Operating margin | -21.9% | -1.6% | -3.6% | 0.3% | -4.7% |
| Net margin | -28.5% | -2.4% | -5.8% | -1.4% | -4.1% |
| Return on assets | -28.1% | -2.4% | -4.2% | -1.1% | -2.6% |
| Return on equity | -128.7% | -6.2% | -10.6% | -2.2% | -5.4% |
| Debt / equity | 2.34× | 0.49× | 0.56× | 0.48× | 0.31× |
| Current ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
| Revenue growth | -26.6% | 30.1% | 45.3% | 48.9% | -1.8% |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3 (distress)
- Working capital / assets 0.064
- Retained earnings / assets -0.693
- EBIT / assets -0.216
- Equity / liabilities 0.28
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001628908 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.